Peptide Therapeutics Forum 2023
Program
«Fibroblast activation protein (FAP) targeting radiopharmaceuticals: FAP-2286 and beyond»
«Current European regulatory expectations for synthetic peptides»
«Proteome-Derived Peptide Probes for Biomedical Research & Imaging»
«Platforms for the intracellular generation and high-throughput screening of cyclic peptide libraries»
«Chemical synthesis of c-Myc transactivation domain using a synthesis/solubility tag»
Elyse Williams, University of Zurich
«Synthetic c-Myc1-84 library allows correlation of PTMs and PTM-crosstalk with binding interactions»
Xinjian Ji, EPFL Lausanne
«Synthesis and screening large libraries of cyclic peptides for addressing intracellular protein-protein interactions»
Franz Waibl, ETH Zurich
«Computational modelling for membrane permeation of cyclic peptides»
Prof. Markus Kaiser, University of Essen, DEU
«Peptide natural Products as starting points for chemical probe design»
«Development of a pan ras inhibitor»
«Omomyc: Bringing the first anti-Myc mini-protein into the clinic»
«Live-cell membrane protein semi-synthesis using protein trans-splicing»
Assoc. Prof. Christian Ottmann, Eindhoven University of Tehnology, NL (online)
«Protein-protein interactions as exemplified for 14-3-3»
«New frontiers for peptide drug discovery in diabetes and obesity»
«Two bites at the apple: design and repair of peptide therapeutics»
«Accomplishing an unprecedented 115 kg GMP campaign of MK-0616 through innovation and strategic planning»
Assoc. Prof. Yu-Shan Lin, Tufts University, Medford, USA
«Structure prediction of cyclic peptides via molecular dynamics and machine learning»
Mirja Harms, Ulm University Medical Center
«Preclinical development of the endogenous CXCR4 antagonist EPI-X4 for therapy of cancer and inflammatory diseases»
Dr. Rumit Maini, PepLib Boston
«Peptide information compression technology (PICT) for GPCR drug discovery using cell-based Functional high-throughput screening assays»
Young Do Yoo, Korea University
«A novel peptide derived from the mitochondrial protein, Romo1, exhibits the broad antimicrobial activity against the various multidrug-resistant bacteria in vitro and in vivo»
Alessandro Angelini, Ca’ Foscari University of Venice
«A novel combinatorial platform for rapid selection and characterisation of different cyclic peptide stuctures against a wide range of protein targets»
Prof. Kim Lewis, Northeastern University, USA (online)
«Sophisticated peptide antibiotics»